Non-invasive Brain Stimulation System Market to Reach USD 2,802 Million by 2034

According to Statifacts, the global Non-invasive Brain Stimulation System market size was valued at USD 1,465 million in 2024 and is expected to reach USD 2,802 million by 2034, growing at a CAGR of 6.7% from 2024 to 2034.

𝐕𝐢𝐞𝐰 𝐃𝐞𝐭𝐚𝐢𝐥𝐞𝐝 𝐃𝐚𝐭𝐚𝐬𝐞𝐭 (𝐏𝐫𝐢𝐜𝐞: 𝐔𝐒𝐃 1550) ; https://www.statifacts.com/outlook/non-invasive-brain-stimulation-system-market

𝐍𝐨𝐧-𝐢𝐧𝐯𝐚𝐬𝐢𝐯𝐞 𝐁𝐫𝐚𝐢𝐧 𝐒𝐭𝐢𝐦𝐮𝐥𝐚𝐭𝐢𝐨𝐧 𝐒𝐲𝐬𝐭𝐞𝐦 𝐌𝐚𝐫𝐤𝐞𝐭 𝐃𝐞𝐟𝐢𝐧𝐢𝐭𝐢𝐨𝐧

Neurological conditions are increasingly becoming more prevalent globally. Noninvasive Brain Stimulation (NIBS) is used for the diagnosis and adjunct treatment of brain diseases. Noninvasive brain stimulation (NIBS) is safe, painless, and has minimal side effects. This technique is widely adopted by thousands of people around the world to alleviate the effects of issues related to speaking, swallowing, movement, and various other related functions. Transcranial magnetic stimulation (TMS) and transcranial electrical stimulation (tES) are the most popular advanced techniques used to alter brain functions for therapeutic and investigative purposes. NIBS is gaining significant traction among clinicians and researchers due to its promising potential as a neurophysiologic diagnostic tool that can provide non-pharmacological and noninvasive neuromodulatory treatments for various mental diseases.

The rising prevalence of numerous neurological conditions, such as Parkinson's disease, Alzheimer's disease, migraine, and other neuro-related disorders has led to an increasing demand for non-invasive brain stimulation systems. Geriatric people are more susceptible to neurological illnesses. The surge in the aging population is anticipated to drive up the market expansion in the coming years.

The increase in drug approvals by the U.S. Food and Drug Administration (FDA) is projected to lucrative growth opportunities to the market. For instance, In July 2023, Boston Scientific Corporation announced it had received U.S. Food and Drug Administration (FDA) approval for the Vercise Neural Navigator 5 Software, which when used as part of the Vercise Genus Deep Brain Stimulation (DBS) Systems, can provide clinicians with simple and actionable data for efficient programming in the treatment of people living with Parkinson's disease or essential tremor.

𝐓𝐡𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐒𝐭𝐮𝐝𝐲 𝐢𝐬 𝐍𝐨𝐰 𝐀𝐯𝐚𝐢𝐥𝐚𝐛𝐥𝐞 𝐟𝐨𝐫 𝐈𝐦𝐦𝐞𝐝𝐢𝐚𝐭𝐞 𝐀𝐜𝐜𝐞𝐬𝐬 | 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐭𝐡𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐚𝐠𝐞𝐬 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭@ https://www.statifacts.com/download-product/6898

𝐍𝐨𝐧-𝐢𝐧𝐯𝐚𝐬𝐢𝐯𝐞 𝐁𝐫𝐚𝐢𝐧 𝐒𝐭𝐢𝐦𝐮𝐥𝐚𝐭𝐢𝐨𝐧 𝐒𝐲𝐬𝐭𝐞𝐦 𝐌𝐚𝐫𝐤𝐞𝐭 𝐆𝐫𝐨𝐰𝐭𝐡 𝐅𝐚𝐜𝐭𝐨𝐫𝐬

The non-invasive brain stimulation systems market is an emerging sector that is committed to the advancement of cutting-edge technologies that can manipulate brain function without resorting to intrusive procedures. This sector has witnessed substantial expansion, driven by a convergence of factors.

The non-invasive brain stimulation system market has experienced notable growth recently, encompassing technologies such as transcranial magnetic stimulation (TMS) and transcranial electrical stimulation (TES), offering therapeutic and research applications. Industry leaders are dedicated to refining these technologies to meet the diverse demands of the medical, clinical, and research domains, rendering it a dynamic and swiftly evolving sphere.

Numerous elements contribute to the burgeoning of this market. Foremost among these is the surging interest in neuroscience and mental health treatments, which stimulates both research and commercial applications. Non-invasive brain stimulation systems have gained acclaim for their potential in addressing conditions like depression and the management of persistent pain. Moreover, the proliferation of cognitive enhancement therapies and their applicability in neurological disorders further stoke market expansion.

Moreover, the advent of cutting-edge technologies and a more profound comprehension of brain functions have cleared the path for ingenious solutions. This encompasses the advent of personalized treatment options, as non-invasive brain stimulation systems can be customized to individual patients, heightening their efficacy and attractiveness in the medical sector.

Despite its promising prospects, the non-invasive brain stimulation system market encounters challenges. Regulatory obstacles and the need for stringent clinical validation represent hurdles to market growth.

Additionally, intense competition among industry participants striving to create more efficient and cost-effective devices is a persistent challenge. Furthermore, addressing ethical concerns and potential side effects associated with brain stimulation therapies is imperative to foster public trust.

Within these challenges, numerous business prospects emerge within the non-invasive brain stimulation system market. Collaborative ventures between technology enterprises and research institutions can lead to groundbreaking discoveries and inventive solutions. Expanding the scope of applications beyond healthcare, such as into the realm of cognitive enhancement, opens up new avenues for revenue.

Furthermore, global market penetration is still in its initial stage, presenting opportunities for market players to broaden their reach into untapped regions. As the comprehension of neurobiology and brain function continues to evolve, the development of pioneering non-invasive brain stimulation systems promises to unlock unexplored therapeutic avenues, positioning the industry for sustained growth in the future.

𝐆𝐫𝐨𝐰𝐢𝐧𝐠 𝐏𝐫𝐞𝐯𝐚𝐥𝐞𝐧𝐜𝐞 𝐨𝐟 𝐍𝐞𝐮𝐫𝐨𝐥𝐨𝐠𝐢𝐜𝐚𝐥 𝐃𝐢𝐬𝐨𝐫𝐝𝐞𝐫𝐬 𝐚𝐧𝐝 𝐃𝐢𝐬𝐞𝐚𝐬𝐞𝐬 𝐢𝐬 𝐃𝐫𝐢𝐯𝐢𝐧𝐠 𝐃𝐞𝐦𝐚𝐧𝐝 𝐟𝐨𝐫 𝐍𝐨𝐧-𝐈𝐧𝐯𝐚𝐬𝐢𝐯𝐞 𝐁𝐫𝐚𝐢𝐧 𝐒𝐭𝐢𝐦𝐮𝐥𝐚𝐭𝐢𝐨𝐧 𝐒𝐲𝐬𝐭𝐞𝐦𝐬

The market for non-invasive brain stimulation systems is predicted to see growth due to an increase in the number of persons suffering from neurological illnesses in key regions of the world. Neurological problems are becoming more common as the geriatric population worldwide goes up. This is driving up demand for non-invasive brain stimulation systems, which is, in turn, driving up market expansion.

Governments of many developed and developing countries provide enticing reimbursement plans for healthcare institutions. The non-invasive brain stimulation system market is growing in terms of sales based on this ground as well.

The function of the brain is investigated using functional MRI (magnetic resonance imaging) and EEG (electroencephalogram) methods. The process of stimulating the brain is also used to promote mental activity. The two techniques for brain stimulation are repeated transcranial magnetic stimulation (TMS) and transcranial current stimulation (TCS). These two procedures, which are collectively referred to as non-invasive brain stimulation, are used to both enhance brain function and disrupt brain activity. Over the forecast period, the increasing relevance of these techniques is anticipated to encourage the growth of the worldwide non-invasive brain stimulation system market.

The industry's leading companies are concentrating on getting new non-invasive brain stimulation systems approved and put on the market in order to increase the variety of products they provide. In addition, major industry competitors are concentrating on releasing improved versions of their non-invasive brain stimulation systems in the market. The industry is anticipated to increase as new technologies are increasingly used by hospitals.

𝐈𝐦𝐦𝐞𝐝𝐢𝐚𝐭𝐞 𝐃𝐞𝐥𝐢𝐯𝐞𝐫𝐲 𝐢𝐬 𝐀𝐯𝐚𝐢𝐥𝐚𝐛𝐥𝐞 | 𝐆𝐞𝐭 𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭 𝐀𝐜𝐜𝐞𝐬𝐬@ https://www.statifacts.com/order-report/6898

𝐍𝐨𝐧-𝐢𝐧𝐯𝐚𝐬𝐢𝐯𝐞 𝐁𝐫𝐚𝐢𝐧 𝐒𝐭𝐢𝐦𝐮𝐥𝐚𝐭𝐢𝐨𝐧 𝐒𝐲𝐬𝐭𝐞𝐦 𝐌𝐚𝐫𝐤𝐞𝐭 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬
• Brainbox Ltd.
• BrainsWay
• eNeura Inc.
• Flow Neuroscience
• Magnus Medical, Inc.
• Magstim
• MagVenture
• NeoSync, Inc. (Wave Neuroscience, Inc.)
• NeuraLace
• Neurocare Group AG
• NeuroMetrix
• Neuronetics
• Soterix Medical, Inc.

𝐑𝐞𝐜𝐞𝐧𝐭 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭𝐬

• In 2021, Magstim, a company specializing in neuroscience-based treatments and research for mental health, secured 510K approval for its Horizon 3.0 system. Horizon 3.0, primarily designed for clinical settings, offers streamlined workflows featuring guided Transcranial Magnetic Stimulation (TMS) and advanced analytics. Complementing this, Magstim Connect introduces a robust patient data management system for TMS, enabling seamless treatment coordination across networks of healthcare facilities.

• In 2022, Magnus Medical, Inc. achieved FDA clearance for its SAINT Neuromodulation system, a groundbreaking advancement in non-invasive treatment tailored for severe depression. This innovative system offers precision and customization in addressing this challenging condition.

• In 2022 witnessed a significant milestone for BrainsWay as they secured U.S. FDA approval for the H7 coil. This specialized coil facilitates deep Transcranial Magnetic Stimulation (TMS), a transformative approach for treating major depressive disorder and anxious depression in adults.

• In 2020, Wave Neuroscience, Inc. bolstered its product portfolio and solidified its position in the EEG and EEG/EKG guided TMS sector through the acquisition of NeoSync, Inc. This strategic move marked a pivotal step in expanding their offerings and expertise in this evolving field.

𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐬 𝐂𝐨𝐯𝐞𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭

By Product

• Transcranial Magnetic Stimulation (TMS) System
• Transcranial Current Stimulation (TCS) System

By End-user

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Others

By Application

• Depression
• Epilepsy
• Parkinson's Disease
• Chronic Pain
• Others

By Geography

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

𝐑𝐞𝐚𝐬𝐨𝐧𝐬 𝐭𝐨 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors

• Provision of market value (USD Million/ Billion) data for each segment and sub-segment

• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

• Includes in-depth analysis of the market from various perspectives through Porter's five forces analysis

• Provides insight into the market through Value Chain

• Market dynamics scenario, along with growth opportunities of the market in the years to come

• 6-month post-sales analyst support
𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐒𝐚𝐥𝐞𝐬 𝐟𝐨𝐫 𝐅𝐮𝐫𝐭𝐡𝐞𝐫 𝐀𝐬𝐬𝐢𝐬𝐭𝐚𝐧𝐜𝐞 𝐢𝐧 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐢𝐧𝐠 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭@ https://www.statifacts.com/order-report/6898

You can place an order or ask any questions, please feel free to contact at sales@statifacts.com| +44 7383 092 044

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬:
Ballindamm 22, 20095 Hamburg, Germany
Email: sales@statifacts.com
Europe : +44 7383 092 044

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:
Statifacts is a leading provider of comprehensive market research and analytics services, offering over 1,000,000 market and customer data sets across various industries. Their platform enables businesses to make informed strategic decisions by providing full access to statistics, downloadable in formats such as XLS, PDF, and PNG.

Visit Our Sitemap: https://www.statifacts.com/outlook/sitemap.xml

This release was published on openPR.